Merck & Co., Inc
Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportAug 7 →InsidersNo open-market buys. 10 insiders sold $42.0M, 0 of 18 sales on a 10b5-1 plan.→HoldersBlackRock 6.3%Vanguard 4.5%State Street 3.4%→PeersClosest companies: BMY, ARVN, AMGN→
From the filings
Figures
- Revenue
- $66.57Blast 12 months
- Net income
- $3.17Blast 12 months
- Operating cash flow
- $17.89Blast 12 months
- Cash and equivalents
- $6.85Bat the last balance sheet
- Total debt
- $53.91Bat the last balance sheet
- Shares outstanding
- 3.58B shareson issue